Skip to main content
UHS logo

Universal Health Services, Inc. (UHS) Stock: Price, Forecast & Analyst Target

Universal Health Services, Inc. (UHS) — MoonshotScore 91/100 (Exceptional band), calculated Nov 18, 2026. Price $186.07 (-3.08%), as of the Nov 18, 2026 trading session; market cap $10.7B. Expected results Feb 24, 2027.

Educational signal · not a buy or sell recommendation · How to read this

Market value / cash and short-term investments: 63.41× (cash as of Sep 30, 2026) · expected results Feb 24, 2027

$186.07 −$5.91 (-3.08%) Market Cap $10.7B

Universal Health Services, Inc. · UHS · NYSE · Healthcare · Medical - Care Facilities

Research dated 2026-09-13: Universal Health Services earns most of its revenue by treating patients in acute-care hospitals and behavioral-health facilities, with outpatient sites, facility management and commercial health insurance extending that base. The case depends on whether rising revenue and cash generation can outrun softer patient-volume expectations, reimbursement pressure and a debt load that dwarfs cash.

Price as of Nov 18, 2026

Key Statistics

91 of 100

MoonshotScore v2 · Universal Health Services (UHS)

Exceptional
Business Quality Elite (90)
Financial Safety Strained (37)
Valuation Cheap (90)
Growth Durability Compounding (89)
Momentum Rising (77)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality and elite growth, at a dirt-cheap price, but a strained balance sheet; the market is already moving on it. Business Quality: Elite; Financial Safety: Strained; Valuation: Cheap; Growth Durability: Compounding; Momentum: Rising.

  • EPS beat 0 of the last 4 reports
  • Altman Z 2.16 · Piotroski F 6
  • ROE 19.7% · ROA 7.7% · current ratio 1.37

Helping: business quality, an attractive price, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for UHS (57 recorded, newest six shown)
RecordedScoreBand
91Exceptional
92Exceptional
92Exceptional
92Exceptional
91Exceptional
91Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$186.07
Change on the day-3.08%
52-week range$140.08–$246.33
Market capitalisation$10.7B—
Price / earnings (trailing)7.96
Shares traded on the day674.0K
Beta (volatility vs the S&P 500)1.11
Dividends per share (last 12 months)$0.80
Dividend yield (last 12 months)0.42%

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 18, 2026: low $141, high $244, latest $186. 4 reported quarters marked, 3 above and 1 below the recorded estimate. 1 other dated event marked. $244 $141 high $244 Feb 25, 2026 · Earnings results · reported below the recorded estimate · close $2061Apr 27, 2026 · Earnings results · reported above the recorded estimate · close $1742Jul 27, 2026 · Earnings results · reported above the recorded estimate · close $1563Oct 27, 2026 · Earnings results · reported above the recorded estimate · close $1764Oct 28, 2026 · Earnings call · management outlook · no recorded estimate to compare · close $1765 Oct 17, 2025 Nov 18, 2026 · $186 $205Oct 17, 2025$217Oct 31, 2025$225Nov 14, 2025$244Nov 28, 2025$223Dec 12, 2025$228Dec 26, 2025$207Jan 9, 2026$205Jan 23, 2026$219Feb 6, 2026$230Feb 20, 2026$193Mar 6, 2026$186Mar 20, 2026$177Apr 2, 2026$182Apr 17, 2026$167May 1, 2026$169May 15, 2026$146May 29, 2026$146Jun 12, 2026$146Jun 26, 2026$156Jul 10, 2026$156Jul 24, 2026$174Aug 7, 2026$177Aug 21, 2026$170Sep 4, 2026$177Sep 18, 2026$176Oct 2, 2026$185Oct 16, 2026$176Oct 30, 2026$194Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · below the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings call · management outlook

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate

Management outlook

  • As several acute care de novo and expansion projects are now completed, we expect CapEx to moderate towards $800 million beyond 2026.

    Steve Filton · Statement from

  • We intend to discuss anticipated synergies in greater detail when we provide 2027 guidance in February.

    Marc Miller · Statement from

How to read these dates

A statement's date is the earnings call where it was made, not a deadline. Management expectations and estimated dates can change.

Read management statements

Other perspectives

Council score for Universal Health Services (UHS): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Strong
Financial Safety Weak
Valuation Strong
Growth Durability Strong
Momentum Moderate

Legends Council

5 lenses, 5 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Favorable read

Read on: Nov 19, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Moderate
Margin of Safety Undervalued
Profit Margin Neutral
Debt/Equity Weak
ROE Moderate
Gross Margin Moderate

Read on: Nov 19, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

Three of these lenses read this company less favourably than the MoonshotScore does: Griffin-style lens, Englander-style lens and Klarman-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

The Munger lens reads the current price as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Universal Health Services (UHS), and what does it report?

Short answer · as of

UHS owns and manages acute-care hospitals, behavioral-health treatment centers and related outpatient facilities.

Acute care contributes more revenue, but behavioral health is substantial enough that UHS should not be read as merely a general-hospital operator; its services range from surgery, emergency medicine and oncology to mental-health treatment.

Reported revenue therefore measures care delivered across distinct settings and demand units. Acute-care activity is discussed through adjusted admissions, while behavioral-health activity is tracked through patient days; commercial insurance and centralized management services add further operating breadth.

2 · Latest results

What do the latest results show for Universal Health Services (UHS)?

The latest reported period extended the longer run of revenue growth and produced higher operating profit, net income and diluted earnings than the comparable period. Revenue and earnings also exceeded market expectations, following a mixed history in which earnings execution was generally steadier than revenue execution.

Management nevertheless reduced its volume outlook for acute care and behavioral health after softer activity trends. It also expects exchange-related pressure near the unfavorable end of its prior range, citing enrollment and metal-tier shifts, while a Texas behavioral-health hospital is operating with limited census and losses during recertification.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Latest quarter · revenue
$4.73B Sep 30, 2026
Latest quarter · SG&A
$0.00 Sep 30, 2026
Latest quarter · FMP standardized operating result
$454.45M Sep 30, 2026
Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026$4.73BNot available$0.00$454.45M
Jun 30, 2026$4.64BNot available$2.14B$516.67M
Mar 31, 2026$4.50BNot available$2.13B$502.86M
Dec 31, 2025$4.49BNot available$2.09B$517.23M
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$4.73B Oct 27, 2026
Latest report · revenue estimate
$4.71B Oct 27, 2026
Latest report · revenue vs estimate
Above estimate Oct 27, 2026
Latest report · EPS vs estimate
Above estimate Oct 27, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Oct 27, 2026$4.73B$4.71B$5.2200$5.1900
Jul 27, 2026$4.64B$4.58B$5.9800$5.9400
Apr 27, 2026$4.50B$4.39B$5.6200$5.4100
Feb 25, 2026$4.49B$4.50B$5.8800$5.9200
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2025$4.50B$373M$5.74 (diluted)
Q4 FY2025$4.49B$446M$7.01 (diluted)
Q1 FY2026$4.50B$349M$5.65 (diluted)
Q2 FY2026$4.64B$358M$5.98 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Universal Health Services (UHS)?

Short answer

Cash and short-term investments were $168.75M at the Sep 30, 2026 balance-sheet date. Operating cash flow was $636.56M for the quarter ended Sep 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.

Operating cash flow has remained positive and has exceeded capital spending throughout the displayed quarterly series. That gives UHS internally generated funding for a facility-heavy model, and trailing profitability and return measures remain healthy.

The balance sheet is the sharper constraint. Cash has stayed within a relatively narrow range while debt is far larger, leaving substantial net debt despite near-term liquidity ratios around balance. Continued dividends add a recurring cash commitment, though recent payments have been stable.

The business is especially exposed when reimbursement stops but facility costs continue. The Texas recertification case makes that mechanism concrete: restricted patient activity and unavailable government or managed-care reimbursement are expected to produce operating losses.

How much cash does the business generate or use?

Quarterly operating cash flow shows cash generated or used by operations.

Latest quarter · operating cash flow
$636.56M Sep 30, 2026
Previous quarter · operating cash flow
$443.30M Jun 30, 2026
Period endOperating cash flowCapital expenditure (reported)
Sep 30, 2026$636.56M−$214.94M
Jun 30, 2026$443.30M−$227.63M
Mar 31, 2026$401.63M−$217.16M
Dec 31, 2025$574.69M−$281.22M
How to read these figures

Amounts are in US dollars. Negative operating cash flow means the business used cash. Capital spending is shown as reported; we do not combine it into a free-cash-flow or runway estimate. The bars share one scale.

4 · What to check next?

What should you watch next at Universal Health Services (UHS)?

Short answer · as of

The next earnings report is expected on Feb 24, 2027.

Watch acute-care adjusted admissions and behavioral-health patient days against management’s reduced ranges. Stabilization would support the revenue trend; further weakening would make recent profit growth harder to sustain, particularly while exchange reimbursement remains a headwind.

The scheduled earnings update carries expectations for higher revenue but softer per-share earnings than the latest reported period. Cash conversion after capital spending, debt movement and any update on the Texas facility’s certification should matter more than a headline revenue beat by itself.

Recent filings also include material agreements and borrowing-related disclosures. Given the gap between debt and cash, changes in financing commitments deserve attention alongside operating results.

What management is planning

Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.

  1. During the third quarter of 2026, we spent $214 million on capital expenditures, and we anticipate capital expenditures to be slightly below $1 billion for the full-year of 2026.

    Steve Filton ·

  2. Based on year-to-date trends through the third quarter and the ongoing ramp of acute care hospitals in Washington, D.C., and Palm Beach Gardens Hospital, Florida, we currently expect results to be towards the lower end of these ranges.

    Steve Filton ·

2 more statements are quoted under Upcoming events

5 · Peer comparison

How does Universal Health Services compare with its peers?

Short answer

Universal Health Services's score ranks 3rd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Against a pure acute-care hospital operator, UHS has a meaningful behavioral-health platform whose demand is reflected in patient days rather than hospital admissions. Against a behavioral-health specialist, it has a larger acute-care operation spanning emergency, surgical, diagnostic and specialty medicine.

That mix diversifies the settings in which UHS treats patients, but it does not remove shared exposure to reimbursement and facility utilization. Ownership and management of facilities, centralized support functions and a commercial insurance operation also make the model broader than a straightforward collection of hospitals.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Tenet Healthcare Corporation (THC) Same industry, near in market value$271.34 Nov 18, 2026$21.6B94 5-pillar Nov 18, 2026
LifeStance Health Group, Inc. (LFST) Same industry, near in market value$13.77 Nov 18, 2026$5.24B92 5-pillar Nov 18, 2026
Universal Health Services (UHS) — this page$186.07$10.7B91
Chemed Corporation (CHE) Same industry, near in market value$546.72 Nov 18, 2026$7.09B85 5-pillar Nov 18, 2026
Option Care Health, Inc. (OPCH) Same industry, near in market value$31.71 Nov 18, 2026$4.75B85 5-pillar Nov 18, 2026
Pediatrix Medical Group, Inc. (MD) Same industry, near in market value$30.84 Nov 18, 2026$2.41B82 5-pillar Nov 18, 2026
Encompass Health Corporation (EHC) Named competitor$134.94 Nov 18, 2026$13.2B81 5-pillar Nov 18, 2026
Fresenius Medical Care AG & Co. KGaA (FMS) Named competitor$20.95 Nov 18, 2026$10.9B80 5-pillar Nov 18, 2026
HCA Healthcare, Inc. (HCA) Named competitor$476.35 Nov 18, 2026$99.5B77 5-pillar Nov 18, 2026
DaVita Inc. (DVA) Named competitor$161.75 Nov 18, 2026$10.2B76 5-pillar Nov 18, 2026
National HealthCare Corporation (NHC) Same industry, near in market value$201.60 Nov 18, 2026$3.16B76 5-pillar Nov 18, 2026
The Ensign Group, Inc. (ENSG) Named competitor$182.98 Nov 18, 2026$10.7B74 5-pillar Nov 18, 2026
Solventum Corporation (SOLV) Same industry, near in market value$86.48 Nov 18, 2026$14.7B66 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$156.00 – $290.00
Consensus target
$193.13
Median target
$186.50

Consensus record · Captured .

Measured against a quoted price of $186.07 (as of Nov 18, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 11, 2026

Transactions
16
Identified insiders
2
Purchases
0
Sales
0
Other transactions
16

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Institutional ownership
86.3% Period end Sep 30, 2026
Previous quarter · ownership
86.5% Prior to period end Sep 30, 2026
Reporting holders
653 Period end Sep 30, 2026
Previous quarter · holders
618 Prior to period end Sep 30, 2026
Holders in provider snapshotShares
First Eagle Investment Management, LLC4,565,943
Blackrock, INC.3,900,560
Vanguard Capital Management LLC3,296,153
Dimensional Fund Advisors LP2,679,916
Pzena Investment Management LLC2,607,221

Tracked investors

Which of the 16 named investors we follow held UHS in their latest 13F filing, and what they did against the filing before it.

InvestorManager13F quarterPortfolio weightValueLast quarter
Bridgewater AssociatesFounded by Ray DalioQ3 20260.14%$32.41MTrimmed −18.5% shares

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Holder snapshot as of Sep 30, 2026. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Universal Health Services (UHS)?

Read these with our analysis →

Common Questions About UHS (Healthcare)

The last 3 questions are answered from this page's own dated data, not from the research.

Why do UHS acute-care admissions and behavioral-health patient days matter separately?

They represent different units of demand inside UHS. Acute-care performance depends on adjusted admissions, while behavioral-health performance depends on occupied treatment days, so weakness can emerge on either side without moving in lockstep.

What is happening at the UHS behavioral-health hospital in Texas?

The facility stopped receiving government and managed-care reimbursement while seeking recertification. UHS expects limited patient census and operating losses during that process.

Does UHS operate as a health insurer as well as a hospital company?

UHS provides commercial health insurance, but acute-care hospitals and behavioral-health services remain its principal reported revenue segments. Insurance broadens the model without replacing patient care as its economic core.

Why can UHS revenue rise while patient-volume guidance falls?

Reported revenue and profit describe completed activity across the whole business, whereas management’s guidance addresses the pace of future admissions and patient days. The latest results remained strong even as management tempered volume expectations and highlighted exchange-related reimbursement pressure.

What is the UHS stock price today?

The last price recorded for Universal Health Services, Inc. (UHS), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the UHS price target?

The analyst consensus price target for Universal Health Services, Inc. (UHS), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Does UHS pay a dividend?

Yes. The dividend yield of Universal Health Services, Inc. (UHS) over the last 12 months, with its date, is listed under Price & valuation on this page. Payout ratio and cash-flow coverage decide whether it can last, and past dividends do not guarantee future payments.

Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 79 figures on this page — 2 from SEC filings and earnings calls, 68 from Financial Modeling Prep (FMP), 3 with no recorded source, 5 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-13), by section of the research

  • Summary at the top of the page: Business description; Revenue by segment; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash, investments and debt; Management outlook — dated call excerpts
  • 1. What is Universal Health Services (UHS), and what does it report?: Business description; Revenue by segment; Employees; Management outlook — dated call excerpts
  • 2. What do the latest results show for Universal Health Services (UHS)?: Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts
  • 3. What are the financial strengths and risks for Universal Health Services (UHS)?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Cash against market value; Trailing twelve-month ratio set; Distress and quality screens; Recent dividends paid; Management outlook — dated call excerpts
  • 4. What should you watch next at Universal Health Services (UHS)?: Management outlook — dated call excerpts; Next earnings report; Analyst revenue and earnings estimates (average); Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash, investments and debt; Recent SEC filings; Most recent periodic reports
  • 5. How does Universal Health Services compare with its peers?: Business description; Revenue by segment; Management outlook — dated call excerpts; Annual revenue and net result (USD millions); Trailing twelve-month ratio set
  • FAQ: Why do UHS acute-care admissions and behavioral-health patient days matter separately?: Business description; Revenue by segment; Management outlook — dated call excerpts
  • FAQ: What is happening at the UHS behavioral-health hospital in Texas?: Management outlook — dated call excerpts
  • FAQ: Does UHS operate as a health insurer as well as a hospital company?: Business description; Revenue by segment
  • FAQ: Why can UHS revenue rise while patient-volume guidance falls?: Quarterly income statement (USD thousands); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.